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Coronaviruses (CoVs) are the largest group of viruses
belonging to the Nidovirales order. They are enveloped, non-
segmented positive-sense RNA viruses [1]. The Novel Coronavi-
rus (2019-nCoV), also known as Wuhan coronavirus, causes the
2019-nCoV acute respiratory disease, or COVID-19. The initial
cases of 2019-nCoV occurred in Wuahn, China in December 2019
[2]. Based on a recent epidemiologic study there is evidence that
human-to-human transmission has occurred among close
contacts since the middle of December 2019 [3]. As of 3
February 2020, 17,238 laboratory-confirmed cases of 2019-nCoV
have been reported including 361 deaths [4]. The disease has
already spread to 19 countries outside China, with new cases
continuing to emerge daily. Recently, Chen et al. reported nine
cases of pregnant women with 2019-nCoV [5]. While coronavi-
rus infection is a common and usually self-limiting infection, in
a specific population like pregnant women, complications of the
disease appear to be more relevant, and pregnant women are
particularly susceptible to morbidity and mortality, especially in
case of high pathogenicity CoVs such as severe acute respiratory
syndrome (SARSCOV) or Middle East respiratory syndrome
(MERSCOV) [6].
Prior cases of CoVs in pregnancy have been reported. Wong et al.
[7] reported pregnancy and perinatal outcomes of women with
severe acute respiratory syndrome, including 12 cases of SARS-CoV
during the 2002–2003 pandemic. Of them, more than 50 % of the
women reported early abortion with first-trimester infection,
while in those who contracted the virus in the second-trimester, 40
% of intrauterine growth restriction, and 80 % of preterm deliveryTable 1
Published cases of MERSCOV, SARSCOV, and 2019-nCoV in pregnant women.
Wong 20047 Alfaraj 
Infection SARS-COV MERS-C
Number of infected women 12 11 
Women with first trimester infection 7 1 
Abortion in women with first trimester infection 4/7 (57.1 %) 0/1 
Women with second or third trimester infection 5 10 
IUGR in women with second or third trimester infection 2/5 (40.0 %) Not rep
PTB in women with second or third trimester infection 4/5 (80.0 %) 3/10 (3
Cesarean delivery 4/5 (80.0 %) 4/10 (4
Stillbirth 0/5 2/10 (2
Neonatal death 0/12 1/10 (1
Clinical or serologic evidence of vertical trasmission 0/12 0/11 
Admission to ICU Not reported 7/11 (6
Maternal death 3/12 (25 %) 3/11 (2
MERSCOV, Middle East respiratory syndrome; SARSCOV, severe acute respiratory synd
unit.
* One neonate not tested.
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pregnancy. Alfaraj et al. [8] reported in a literature review 11 cases
of patients with Middle East respiratory syndrome (MERSCOV)
during pregnancy. Of them 91 % had adverse outcomes, with three
perinatal deaths.
Four papers on 2019-nCoV in pregnancy have been published so
far.591,011 Chen S. et al. in a paper published in Chinese described
clinical characteristics and placental pathology of three women
with confirmed 2019-nCoV who delivered by cesarean delivery [9].
All women presented with fever, one before delivery and two in
postpartum. Authors found various degrees of fibrin deposition
inside and around the villi with local syncytial nodule increases in
all three placentas. One case of placenta showed the concomitant
morphology of chorionic hemangioma and another one with
massive placental infarction. No pathological change of villitis and
chorioamnionitis was observed in our observation of three cases.
All samples from three placentas were negative for the nucleic acid
of 2019-nCoV [9]. Chen H. et al. reported data from nine pregnant
women with 2019-nCoV [5]. No clinical or serologic evidence of
vertical trasmission was noticed, and no neonatal deaths were
reported [5]. Chen Y et al. [10] reported data from four full-term
singleton infants who were born to pregnant women tested
positive for 2019-nCoV in the city of Wuhan. Of the three infants,
for who consent to be diagnostically tested was provided, none
tested positive for the virus. None of the infants developed serious
clinical, and all four infants were alive at the time of hospital
discharge [10].
The overall maternal and perinatal outcomes of pregnant
women with SARSCOV and MERSCOV are reported in Table 1.
Notably, infection of 2019-nCoV during pregnancy seems less
serious compared to infection of SARSCOV and MERSCOV with
no cases of maternal death, or perinatal death.20198 Chen H. 20205 Chen S. 20209 Chen Y. 202010 Total
OV 2019-nCoV 2019-nCoV 2019-nCoV –
9 3 4 39
0 0 0 8
– – – 4/8 (50.0 %)
9 3 4 31
orted 0/9 Not reported Not reported 2/14 (14.3 %)
0.0 %) 4/9 (44.4 %) 1/3 (33.3 %) 0/4 12/31 (38.7 %)
0.0 %) 9/9 (100 %) 3/3 (100 %) 3/4 (75.0 %) 23/31 (74.2 %)
0.0 %) 0/9 0/3 0/4 2/31 (6.5 %)
0.0 %) 0/9 0/3 0/4 1/38 (2.6 %)
0/9 0/3 0/3* 0/39
3.3 %) Not reported Not reported Not reported 7/11 (63.3 %)
7.3 %) 0/9 0/3 0/4 6/39 (15.4 %)
rome; IUGR, intrauterine growth restriction; PTB, preterm birth; ICU, intensive care
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nCoV is firmly reccomended. Obstetricians should promptly
recognize the symptoms of 2019-nCoV, and adequately assess
severity and fetal well-being.
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